EIPICO PHARMA, EGYPT Report issue

For profit Phase 4

Organization Overview

First Clinical Trial
2013
NCT04605107
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

EIPICO PHARMA, EGYPT